anaplastic lymphoma kinase inhibitors (ChemBridge Research)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameanaplastic lymphoma kinase inhibitors (ChemBridge Research)
Drug Alias NameALK inihibitors (ChemBridge Research)CRL-43425CRL-82007CRL-37212
ClassificationSmall molecules
Mechanisms of ActionAnaplastic lymphoma kinase inhibitorsAnticancer protein kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemBridge Research Laboratories LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemBridge Research Laboratories LLC
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A